NLS Pharmaceutics(NLSP.US)

Last Updated 19:00:00 ET
longbridge loading

Agomab Announces Launch of Initial Public Offering

fidelity·
US
APGE
+1.14%
US
NLSP
0.00%
US
SBIO
+1.80%
fidelity·
US
APGE
+1.14%
US
NLSP
0.00%
US
SBIO
+1.80%

NLS Pharmaceutics Expands CNS Pipeline with AEX-6xx Series

Tip Ranks·
US
NLSP
0.00%
Tip Ranks·
US
NLSP
0.00%

Pre-market hot trades in the US stock market: NLS Pharmaceutics up 10.12% in pre-market; Cleveland Cliffs down 9.58% in pre-market

Price Alert·
US
NLSP
0.00%
US
CLF
+4.50%
Price Alert·
US
NLSP
0.00%
US
CLF
+4.50%

NLS Pharmaceutics shares are trading lower after the company announced its plans to effect a reverse share split at 1-for-10, effective October 31.

benzinga_article·
US
NLSP
0.00%
benzinga_article·
US
NLSP
0.00%

NLS Pharmaceutics and Kadimastem Continue ITOL-102 Diabetes Program Post-Merger

Tip Ranks·
US
NLSP
0.00%
US
NCEL
-2.15%
Tip Ranks·
US
NLSP
0.00%
US
NCEL
-2.15%
© 2026 Longbridge｜Disclaimer